The association between cytochrome P450 polymorphisms and anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.

Author: DengFei, FengJing, JiangFeifei, JiangPeidu, LiuXingren, RenSong, XuDalin, ZhangJingwei

Paper Details 
Original Abstract of the Article :
Isoniazid (INH), rifampicin (RMP), pyrazinamide (PZA), and ethambutol (EMB) are the four most common drugs for the first-line treatment of tuberculosis (TB). Although chemotherapy drugs are widely used in the treatment of TB, and achieved good results, but the side effects, especially anti-tuberculo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/34154362

データ提供:米国国立医学図書館(NLM)

The Association Between Cytochrome P450 Polymorphisms and Anti-Tuberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis

This comprehensive study investigates the association between genetic variations in cytochrome P450 (CYP) enzymes and the risk of anti-tuberculosis drug-induced liver injury (ATDILI). It's like exploring the vast desert landscape, searching for clues about how certain genetic variations might make individuals more vulnerable to the adverse effects of anti-tuberculosis drugs. The researchers conducted a systematic review and meta-analysis of existing studies, pooling data to assess the strength of the association. Their analysis revealed a complex interplay between CYP polymorphisms and the risk of ATDILI, suggesting that certain genetic variations might influence an individual's susceptibility to liver injury caused by these drugs.

Understanding Genetic Susceptibility: A Key to Personalized Medicine

This study underscores the importance of understanding genetic factors in predicting and managing the risks associated with anti-tuberculosis drug treatment. This is like discovering a hidden map that guides researchers towards a personalized approach to medicine, tailoring treatment strategies based on individual genetic profiles.

Preventing Liver Injury: The Importance of Genetic Screening

The findings highlight the need for further research and development of genetic screening tools to identify individuals at higher risk of ATDILI. This is like having a skilled desert scout who can identify potential hazards and navigate the path to safety.

Dr. Camel's Conclusion

This research takes us on a fascinating journey through the complex world of pharmacogenetics, revealing the intricate connection between genetic variations and drug responses. It emphasizes the importance of individualized medicine, where treatment strategies are tailored to each patient's unique genetic profile. This is like finding a hidden oasis of knowledge in the vast desert of human health, providing valuable insights into the interplay between genes and disease.

Date :
  1. Date Completed 2021-07-12
  2. Date Revised 2021-07-12
Further Info :

Pubmed ID

34154362

DOI: Digital Object Identifier

apm-21-1224

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.